Compartmentation of β2‐adrenoceptor stimulated cAMP responses by phosphodiesterase types 2 and 3 in cardiac ventricular myocytes
Background and Purpose In cardiac myocytes, cyclic AMP (cAMP) produced by both β1‐ and β2‐adrenoceptors increases L‐type Ca2+ channel activity and myocyte contraction. However, only cAMP produced by β1‐adrenoceptors enhances myocyte relaxation through phospholamban‐dependent regulation of the sarco/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2). Here we have tested the hypothesis that stimulation of β2‐adrenoceptors produces a cAMP signal that is unable to reach SERCA2 and determine what role, if any, phosphodiesterase (PDE) activity plays in this compartmentation. Experimental Approach The cAMP responses produced by β1‐and β2‐adrenoceptor stimulation were studied in adult rat ventricular myocytes using two different fluorescence resonance energy transfer (FRET)‐based biosensors, the Epac2‐camps, which is expressed uniformly throughout the cytoplasm of the entire cell and the Epac2‐αKAP, which is targeted to the SERCA2 signalling complex. Key Results Selective activation of β1‐ or β2‐adrenoceptors produced cAMP responses detected by Epac2‐camps. However, only stimulation of β1‐adrenoceptors produced a cAMP response detected by Epac2‐αKAP. Yet, stimulation of β2‐adrenoceptors was able to produce a cAMP signal detected by Epac2‐αKAP in the presence of selective inhibitors of PDE2 or PDE3, but not PDE4. Conclusion and Implications These results support the conclusion that cAMP produced by β2‐adrenoceptor stimulation was not able to reach subcellular locations where the SERCA2 pump is located. Furthermore, this compartmentalized response is due at least in part to PDE2 and PDE3 activity. This discovery could lead to novel PDE‐based therapeutic treatments aimed at correcting cardiac relaxation defects associated with certain forms of heart failure..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:178 |
|---|---|
| Enthalten in: |
British Journal of Pharmacology - 178(2021), 7, Seite 1574-1587 |
| Beteiligte Personen: |
Rudokas, Michael W. [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2021 The British Pharmacological Society |
|---|
| Umfang: |
14 |
|---|
| doi: |
10.1111/bph.15382 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY002938502 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY002938502 | ||
| 003 | DE-627 | ||
| 005 | 20230307122845.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230213s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/bph.15382 |2 doi | |
| 028 | 5 | 2 | |a BPH_BPH15382.xml |
| 035 | |a (DE-627)WLY002938502 | ||
| 035 | |a (WILEY)BPH15382 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.38 |2 bkl | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Rudokas, Michael W. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Compartmentation of β2‐adrenoceptor stimulated cAMP responses by phosphodiesterase types 2 and 3 in cardiac ventricular myocytes |
| 264 | 1 | |c 2021 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2021 The British Pharmacological Society | ||
| 520 | |a Background and Purpose In cardiac myocytes, cyclic AMP (cAMP) produced by both β1‐ and β2‐adrenoceptors increases L‐type Ca2+ channel activity and myocyte contraction. However, only cAMP produced by β1‐adrenoceptors enhances myocyte relaxation through phospholamban‐dependent regulation of the sarco/endoplasmic reticulum Ca2+ ATPase 2 (SERCA2). Here we have tested the hypothesis that stimulation of β2‐adrenoceptors produces a cAMP signal that is unable to reach SERCA2 and determine what role, if any, phosphodiesterase (PDE) activity plays in this compartmentation. Experimental Approach The cAMP responses produced by β1‐and β2‐adrenoceptor stimulation were studied in adult rat ventricular myocytes using two different fluorescence resonance energy transfer (FRET)‐based biosensors, the Epac2‐camps, which is expressed uniformly throughout the cytoplasm of the entire cell and the Epac2‐αKAP, which is targeted to the SERCA2 signalling complex. Key Results Selective activation of β1‐ or β2‐adrenoceptors produced cAMP responses detected by Epac2‐camps. However, only stimulation of β1‐adrenoceptors produced a cAMP response detected by Epac2‐αKAP. Yet, stimulation of β2‐adrenoceptors was able to produce a cAMP signal detected by Epac2‐αKAP in the presence of selective inhibitors of PDE2 or PDE3, but not PDE4. Conclusion and Implications These results support the conclusion that cAMP produced by β2‐adrenoceptor stimulation was not able to reach subcellular locations where the SERCA2 pump is located. Furthermore, this compartmentalized response is due at least in part to PDE2 and PDE3 activity. This discovery could lead to novel PDE‐based therapeutic treatments aimed at correcting cardiac relaxation defects associated with certain forms of heart failure. | ||
| 700 | 1 | |a Post, John P. |4 aut | |
| 700 | 1 | |a Sataray‐Rodriguez, Alejandra |4 aut | |
| 700 | 1 | |a Sherpa, Rinzhin T. |4 aut | |
| 700 | 1 | |a Moshal, Karni S. |4 aut | |
| 700 | 1 | |a Agarwal, Shailesh R. |4 aut | |
| 700 | 1 | |a Harvey, Robert D. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British Journal of Pharmacology |g 178(2021), 7, Seite 1574-1587 |w (DE-627)WLY00292899X |x 14765381 |7 nnns |
| 773 | 1 | 8 | |g volume:178 |g year:2021 |g number:7 |g pages:1574-1587 |g extent:14 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.38 |q ASE |
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 178 |j 2021 |e 7 |h 1574-1587 |g 14 | ||